<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>RSS News Feed for Vernalis - from Laboratorytalk</title>
    <link>http://www.laboratorytalk.com/news/vrn/vrn000.html</link>
    <description>Vernalis news releases on Laboratorytalk</description>
    <language>en-gb</language>
    <copyright>Copyright (C)2008 Pro-Talk Ltd. All rights reserved.</copyright>
    <pubDate>Fri, 25 Apr 2008 08:00:00 UT</pubDate>
    <lastBuildDate>Fri, 25 Apr 2008 08:00:00 UT</lastBuildDate>
    <image>
      <title>Pro-Talk Ltd</title>
      <url>http://www.pro-talk.com/images/protalklogo90.gif</url>
      <link>http://www.pro-talk.com/</link>
      <width>90</width>
      <height>79</height>
    </image>
    <item>
      <title>From Cambridge to Cambridge</title>
      <description>Vernalis (Cambridge, UK) forms cancer research collaboration with Novartis Institutes for BioMedical Research (Cambridge, USA)</description>
      <pubDate>Wed, 24 Dec 2003 08:00:00 UT</pubDate>
      <category>Vernalis</category>
      <link>http://www.laboratorytalk.com/news/vrn/vrn103.html</link>
    </item>
    <item>
      <title>R and D update</title>
      <description>Pharmaceutical development company, which now incorporates British Biotech, has provided a comprehensive update on progress of candidate drugs in its pipeline</description>
      <pubDate>Mon, 08 Dec 2003 08:00:00 UT</pubDate>
      <category>Vernalis</category>
      <link>http://www.laboratorytalk.com/news/vrn/vrn102.html</link>
    </item>
    <item>
      <title>Vernalis integrates British Biotech</title>
      <description>Update on the integration of British Biotech and Vernalis following the completion of the merger of the two companies in September 2003</description>
      <pubDate>Wed, 03 Dec 2003 08:00:00 UT</pubDate>
      <category>Vernalis</category>
      <link>http://www.laboratorytalk.com/news/vrn/vrn101.html</link>
    </item>
    <item>
      <title>Research agreement with AstraZeneca</title>
      <description>Technology platform exploits the detailed molecular structure of drug targets to drive the discovery and design of novel therapeutic molecules</description>
      <pubDate>Wed, 22 Oct 2003 08:00:00 UT</pubDate>
      <category>Vernalis</category>
      <link>http://www.laboratorytalk.com/news/vrn/vrn100.html</link>
    </item>
  </channel>
</rss>
